Predicting the likelihood of remission in children with graves' disease: A prospective, multicenter study

Pediatrics

Volumn 121, Issue 3, 2008, Pages

  Glaser, Nicole S ^a   Styne, Dennis M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Graves' disease; Hyperthyroidism; Propylthiouracil

Indexed keywords

ANTINUCLEAR ANTIBODY; LEVOTHYROXINE; LIOTHYRONINE; PROPYLTHIOURACIL; THIAMAZOLE; THYROID PEROXIDASE ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; THYROXINE; ANTITHYROID AGENT;

ARTHRALGIA; ARTHRITIS; ARTICLE; BODY MASS; CHILD; CLINICAL TRIAL; DRUG WITHDRAWAL; ETHNIC DIFFERENCE; EXOPHTHALMOS; FAMILY HISTORY; FEMALE; GOITER; GRAVES DISEASE; HEMATURIA; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; PREDICTION; PRIORITY JOURNAL; PURPURA; RASH; REMISSION; SIDE EFFECT; STATISTICAL ANALYSIS; THYROID FUNCTION TEST; TREATMENT RESPONSE; ADOLESCENT; AGE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; HOSPITALIZATION; MULTIVARIATE ANALYSIS; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL MODEL; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; ANTITHYROID AGENTS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GRAVES DISEASE; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPYLTHIOURACIL; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; THYROID FUNCTION TESTS; TREATMENT OUTCOME;

EID: 40949125710     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-1535     Document Type: Article

References (32)

1. Baker B, Shapiro B, Fig L, Woodbury D, Sisson J, Beierwaltes W. Unusual complications of antithyroid drug therapy: four case reports and review of Uterature. Thyroidology. 1989;1(1): 17-26
2. Williams K, Nayak S, Becker D, Reyes J, Burmeister L. Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? J Clin Endocrinol Metab. 1997;82(6):1727-1733
3. Moreno P, Gomez J, Gomez N, et al. Subtotal thyroidectomy: a reliable method to achieve euthyroidism in Graves' disease: prognostic Factors. World J Surg. 2006;30( 11 ):1950-1956
4. Palit T, Miller C, Miltenburg D. The efficacy of thyroidectomy for Graves' disease: a meta-analysis. J Surg Res. 2000;90(2): 161-165
5. Read C, Tansey M, Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Grave's patients. J Clin Endocrinol Metab. 2004;89 (9): 4229-4233
6. Rivkees S, Cornelious E. Influence of iodine-131 dose on the outcome of hyperthyroidism in children. Pediatrics. 2003;111 (4 pt l):745-749
7. Schiissler-Fiorenza C, Bruns C, Chen H. The surgical management of Graves' disease. J Surg Res. 2006;133(2):207-214
8. Krassas G, Laron Z. A questionnaire survey concerning the most favourable treatment for Grave's disease in children and adolescents. Ear J Endocrinol 2004; 151 (1):1 55-1 56
9. Webster J, Taback S, Sellers E, Dean H. Graves' disease in children. CMAJ. 2003;169(2):104-105
10. Gruñeiro-Papendieck L, Chiesa A, Finkielstain G, Heinrich J. Pediatric Graves' disease: outcome and treatment. J Pediatr Endocrinol Metab. 2003;16(9):1249-1255
11. Lippe B, Landaw E, Kaplan S. Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. J Clin Endocrinol Metab. 1987;64(6): 1241-1245
12. Cooper D, Goldminz D, Levin A, et al. Agranulocytosis associated with antithyroid drugs: effects of patient age and drug dose. Ann Intern Med. 1983;98(l):26-29
13. Buckingham B, Costin G, Roe T, Weitzman J, Kogut M. Hyperthyroidism in children. Am J Dis Child. 1981;135(2): 112-117
14. Glaser N, Styne D. Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab. 1997;82(6): 1719-1726
15. Hamburger J. Management of hyperthyroidism in children and adolescents. J Clin Endocrinol Metab. 1985;60(5):1019-1024
16. Mäenpää J, Kuusi A. Childhood hyperthyroidism: results of treatment. Acta Paediatr Scand. 1980;69(2):1 37-142
17. Maugendre D, Gatel A, Campion L, et al. Antithyroid drugs and Graves' disease: prospective randomized assessment of longterm treatment. Clin Endocrinol (Oxf). 1999;50( 1 ):127-132
18. Weetman AP. Graves' hyperthyroidism: how long should antithyroid drug therapy be continued to achieve remission? Nat Clin Pract Endocrinol Metab. 2006;2(l):2-3
19. Brieman L, Friedman J, Olshen R, Stone C. Classification and Regression Trees. Washington, DC: Chapman and Hall; 1994
20. Stiell I, Wells G. Methodologic standards for the development of clinical decision rules in emergency medicine. Ann Emerg Med. 1999;33(4):437-447
21. Lee J, Grumbach M, Clark O. The optimal treatment for pediatric Graves' disease is surgery. J Clin Endocrinol Metab. 2007; 92(3):801-803
22. Rivkees S, Dinauer C. An optimal treatment for pediatric Graves' disease is radioiodine. J Clin Endocrinol Metab. 2007; 92(3):797-800
23. Bergman P, Auldist A, Cameron F. Review of the outcome of management of Graves' disease in children and adolescents. J Paediatr Child Health. 2001;37(2): 176-182
24. Sbulman D, Muhar 1, Jorgensen V, Diamond F, Bercu B, Root A. Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid. 1997;7(5): 755-760
25. Gorton C, Sadeghi-Nejad A, Senior B. Remission in children with hyperthyroidism treated with propylthiouracil: long term results. Am J Dis Child. 1987;141 (10):1084-1086
26. Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefsberg Z, Phillip M. Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal children. J Clin Endocrinol Metab. 2000;85(10):3678-3682
27. Botero O, Brown R. Bioassay of thyrotropin receptor antibodies with Chinese hamster ovary cells transfected with recombinant human thyrotropin receptor: clinical utility in children and adolescents with Graves' disease. J Pediatr. 1998; 132 (4): 612-618
28. Marcocci C, Marion M. Thyroid directed antibodies. In: Braver- man L, Utiger R, eds. The Thyroid. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:360-372
29. Shibayama K, Ohyama Y, Yokota Y, Ohtsus S, Takubo N, Mutsuura N. Assays for thyroid stimulating antibodies and thyrotropin binding inhibitory immunoglobulins in children with Graves' disease. Endocr J. 2005;52(5):505-510
30. Foley T, White C, New A. Juvenile Graves' disease: usefulness and limitations of thyrotropin receptor antibody determinations. J Pediatr. 1987;110(3):378-386
31. Huang C, Hsu T, Chou H, Tsay G. Anti-nuclear antibody, anti-DNA, and aCL in Graves' disease patients treated with propylthiouracil or methimazole. lupus. 2004;1 3(6):450-454
32. Nabhan Z, Kreher N, Eugster E. Hashitoxicosis in children: clinical features and natural history. J Pediatr. 2005;146(4): 533-536